Diseases

Diseases

Atherosclerosis I
Co-sponsored by the Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology

Chairs: Katey Rayner, University of Ottawa Heart Institute and
Francis W. Luscinskas, Brigham and Women's Hospital/Harvard Medical School
Matthias Nahrendorf, Harvard Medical School
        Inflammatory networks in cardiovascular disease
Ziad Mallat, University of Cambridge
        Targeting the immune response in ischemic cardiovascular disease

Atherosclerosis II
Co-sponsored by the Korean Vascular Science and Medicine Organization

Chairs: Michael Gimbrone, Brigham and Women's Hospital/Harvard Medical School and
Jun-ichi Abe, University of Texas MD Anderson
Hyo-Soo Kim, Seoul National University Hospital
        Mechanism of calcification in atherosclerosis:
                Role of bone-marrow-derived calcifying progenitors
Ira Tabas, Columbia University
        Defective inflammation resolution in atherosclerosis: Mechanisms and therapeutic implications

Atherosclerosis III
Co-sponsored by the Japanese Vascular Biology and Medicine Organization

Chairs: Myron Cybulsky, Univeristy of Toronto and Yasufumi Sato, Tohoku University
Eicke Latz, University Hospital, University of Bonn
        Innate immune memory in atherosclerosis
Masataka Sata, Tokushima University Graduate School
        Role of innate immunity in chronic inflammation in arterial wall and adipose tissue

Large Vessel Disease Outside the Heart
Co-sponsored by the Japanese Vascular Biology and Medicine Organization

Chairs: Phillip Tsao, Stanford University and Hironori Nakagami, Osaka University
Brian Annex, University of Virginia
        Micro-RNA’s in Peripheral Arterial Disease
Ryuichi Morishita, Osaka University
        Recent progress in molecular medicine on critical limb ischemia:
                From regenerative medicine to vaccine

Neurovascular Disease

Chairs: Elisabetta Dejana, University of Uppsala and Chenghua Gu, Harvard Medical School
Anne Joutel, INSERM - University of Paris
        Novel insight into the pathogenesis of CADASIL
Costantino Iadecola, Weill Cornell Medical College
        Neurovascular dysfunction and cognitive impairment

Pulmonary Hypertension

Chairs: Paul Yu, Brigham and Women's Hospital/Harvard Medical School and
Troy Stevens, University of Alabama
Kurt Stenmark, University of Colorado Denver
        Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension
Evangelos Michelakis, University of Alberta
        The metabolic basic of vascular disease and pulmonary arterial hypertension

Vascular Malformations
Co-sponsored by Cure HHT

Chairs: Ondine Cleaver, University of Texas Southwestern Medical Center and
Joyce Bischoff, Boston Children's Hospita/Harvard Medical School
Miikka Vikkula, de Duve Institute, Université catholique de Louvain
        Deciphering the heterogeneity of vascular malformations by next generation sequencing
Douglas Marchuk, Duke University
        Cerebral cavernous malformations: From gene discovery to potential therapy

Cancer
Co-sponsored by the Korean Vascular Science and Medicine Organization

Chairs: Gabriele Bergers, University of Leuven and
Diane Bielenberg, Boston Children's Hospita/Harvard Medical School
Anna Dimberg, Uppsala University
        Vascular abnormalization in glioblastoma
Gou Young Koh, KAIST
        Molecular targeting of tumor vasculatures

Obesity/Diabetes

Chair: Zoltan Arany, University of Pennsylvania
Kenneth Walsh, Boston University School of Medicine
        Role of adipokines in obesity-linked vascular disease
Ann Marie Schmidt, NYU School of Medicine
        RAGE & the Formin DIAPH1 & mechanisms of diabetic complications

Thrombosis

Chairs: Nigel Mackman, Univeristy of North Carolina and Xiaoping Du, University of Illinois Chicago
Denisa Wagner, Harvard Medical School
        Pathological impact of Neutrophil Extracellular Traps (NETs)
Jose Lopez, Puget Sound Blood Center
      Regulation of von Willebrand factor adhesive function